VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 25, 2011) - Pyng Medical Corp. (the "Company") (TSX VENTURE:PYT) announced today that the T-POD® has been chosen by the Romanian Ambulance Services. The supply contract will be for a period of four years through Pyng's exclusive dealer in Romania, Deltamed Ltd.
Their decision was made after a careful review of pelvic stabilization devices available in the market and after consulting with emergency specialists.
Both Romanian Emergency Services, the Romanian Ambulance and SMURD, the Romanian Mobile Emergency Service for Resuscitation and Extrication, will be using the T-POD® as part of the standard equipment on board their ambulance fleet of about 500 vehicles. "Our customers rely on us to make the best recommendation for which products they should use on their patients. We feel that the T-POD® will not let them down," added Mr. Dan Gorgan, President of Deltamed.
"The T-POD® presents many advantages, the biggest being its one size fits all characteristic. We also liked the uniform/symmetrical compression features and the fact that it is already the standard of care in other European countries. When choosing a product to be placed on board our ambulances, we need one that will be easy to deploy and as effective as possible. By being able to use one product for the majority of patients and by having such positive effects on the blood transfusion requirement, hospital stay, and morbidity, the T-POD® was the only pelvic stabilization device that our customers felt comfortable with," added Mr. Gorgan, who was echoing the feedback from the Romanian Emergency Services.
About Deltamed Ltd.
Deltamed was founded in 1997 as a privately owned company in Cluj-Napoca, Romania. They provide complete solutions for emergency situations including safety equipment, medical supplies, resuscitation equipment, protective equipment, immobilization and transport equipment, diagnostic and therapy equipment, and emergency vehicles.
About Pyng Medical Corp.
Pyng Medical Corp. commercializes award-winning trauma and resuscitation products for front-line critical care personnel. Pyng's expanded product portfolio includes a variety of innovative, lifesaving tools. With growing markets in North America, Europe and Asia, Pyng offers user-preferred medical devices for use by hospital staff, emergency medical services and military forces worldwide.
Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects", "anticipates", "plans", "intends", "projects", "indicates", and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the Company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and development of new products, including regulatory approval and market acceptance; and seasonality of sales in some products.
Neither the TSX Venture Exchange nor its Regulatory Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.